Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | Reccan Diagnostics Ab |
| Country | Sweden |
| Start Date | Jul 03, 2023 |
| End Date | Mar 31, 2024 |
| Duration | 272 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2023-01616_Vinnova |
Purpose and goal: ** Denna text är maskinöversatt **
Reccan aims to improve the prognosis of pancreatic cancer patients by launching a new diagnostic test. The project focuses on strengthening the company´s competence in regulatory areas to meet the requirements for IVD products and certification. Important regulatory documents have been created to ensure that technical documentation is in phase with the project, which was the goal that is considered well met.
Expected results and effects: ** Denna text är maskinöversatt **
Through the project and the expert support, the company´s internal competence in the regulatory area increased. The key people can now independently carry out a similar project. The project resulted in technical documents ready for notified body review as well as templates for the remaining documents. The collaboration has strengthened the organization and enabled future independent project and skills exchange.
Approach and implementation: ** Denna text är maskinöversatt **
During the project´s initial phase, the company´s objective and challenges related to the regulatory work were presented so that the expert would get a good idea of the company´s product and challenges. Afterwards, the need for support and which areas should be prioritised were mapped out together. The writing of the technical documents was carried out together.
Reccan Diagnostics Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant